Finoriq research workspace
WEST PHARMACEUTICAL SERVICES INC (WST) SEC Filings & Filing Highlights
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery. Review WST SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
- Company
- WEST PHARMACEUTICAL SERVICES INC (WST)
- Ticker
- WST
- Market Cap
- $25B
- Latest Price
- $353.87
- Industry
- Medical Devices
WEST PHARMACEUTICAL SERVICES INC (WST) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for WEST PHARMACEUTICAL SERVICES INC (WST).
| Event | Form | Date |
|---|---|---|
| The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 furnish...The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 furnished pursuant to Item 7.01, shall not be deeme... | 8-K7.01 | 2026-06-01 |
| On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on...On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on Form 8-K announcing that Mr. Eric M. Green,... | 8-K5.02 | 2026-06-01 |
| The information in this Item 7.01 of this Current Report on Form 8-K, including the exhibit fur...The information in this Item 7.01 of this Current Report on Form 8-K, including the exhibit furnished pursuant to Item 99.1, shall not be d... | 8-K7.01 | 2026-05-11 |
| The incident’s material impact on the Company’s financial condition and results of operations,...On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity att... | 8-K1.05 | 2026-05-11 |
| Broker Non-VotesWest Pharmaceutical Services, Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders virtually on May 4, 2026. The four proposal... | 8-K5.07 | 2026-05-05 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.